Yasons Chemex Care Ltd
YCCL NSE
Yasons Chemex Care Ltd
CommoditiesNSE: YCCL Dyes And Pigments
Key Fundamentals
SMEDyes & PigmentsChemicalsMarket Cap
₹17.86 Cr
Volatility
Moderate
P/E Ratio
11
EBITDA
₹4.00 Cr
Return on Equity
16.54%
Debt to Equity
0.25
Book Value
₹21.07
EPS
₹0.65
52W High
₹15.4
52W Low
₹9.15
Technical Indicators
Key Insights
Strengths
1- Stock is trading at 0.47 times its book value
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 6.96% over last 3 years.
- Earnings include an other income of Rs.2.31 Cr.
Growth Rate
Revenue Growth
12.96% ↘
Net Income Growth
33.33% ↘
Cash Flow Change
84.90% ↗
ROE
24.76% ↗
ROCE
13.53% ↗
EBITDA Margin (Avg.)
0.59% ↗
Quarterly Results
| Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Depreciation | 0.05 | 0.05 | 0.21 | 0.21 | 0.19 | 0.19 | 0.04 |
| EPS in Rs | 4.56 | 0.52 | 1.46 | -0.81 | 0.97 | -0.13 | 0.53 |
| Expenses | 11.23 | 25.06 | 34.55 | 32.08 | 26.81 | 48.47 | 47.54 |
| Interest | 0.18 | 0.23 | 0.49 | 0.84 | 0.68 | 0.75 | 0.61 |
| Net Profit | 2.69 | 0.74 | 2.82 | -1.57 | 1.88 | -0.25 | 1.02 |
| OPM % | 6.42% | -1.17% | 7.94% | -1.17% | 8.75% | -2.8% | 3.51% |
| Operating Profit | 0.77 | -0.29 | 2.98 | -0.37 | 2.57 | -1.32 | 1.73 |
| Other Income | 2.72 | 1.52 | 1.07 | -0.11 | 0.61 | 2.18 | 0.13 |
| PBT | 3.26 | 0.95 | 3.35 | -1.53 | 2.31 | -0.08 | 1.21 |
| Sales | 12 | 24.77 | 37.53 | 31.71 | 29.38 | 47.15 | 49.27 |
| Tax % | 17.79% | 22.11% | 15.52% | 1.96% | 18.61% | 225% | 16.53% |
Profit & Loss
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| Depreciation | 0.1 | 0.1 | 0.43 | 0.38 | 0.23 |
| Div. Payout % | 0% | 0% | 0% | 0% | — |
| EPS in Rs | 5.81 | 2.42 | 0.65 | 0.84 | 0.4 |
| Expenses | 36.28 | 36.28 | 66.64 | 75.26 | 96.01 |
| Interest | 0.41 | 0.41 | 1.33 | 1.44 | 1.36 |
| Net Profit | 3.43 | 3.43 | 1.25 | 1.62 | 0.77 |
| OPM % | 1.33% | 1.33% | 3.76% | 1.66% | 0.43% |
| Operating Profit | 0.49 | 0.49 | 2.6 | 1.27 | 0.41 |
| Other Income | 4.23 | 4.23 | 0.96 | 2.78 | 2.31 |
| PBT | 4.21 | 4.21 | 1.8 | 2.23 | 1.13 |
| Sales | 36.77 | 36.77 | 69.24 | 76.53 | 96.42 |
| Tax % | 18.76% | 18.76% | 30.56% | 27.35% | — |
Balance Sheet
| Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|
| Borrowings | 3.47 | 8.52 | 11.16 | 13.05 |
| CWIP | 0 | 0 | 0 | 0 |
| Equity Capital | 14.16 | 19.3 | 19.3 | 19.3 |
| Fixed Assets | 0.52 | 3.15 | 2.84 | 3.03 |
| Investments | 6.59 | 0 | 0 | 0 |
| Other Assets | 20.48 | 51.44 | 56.49 | 65.43 |
| Other Liabilities | 3.4 | 7 | 7.49 | 13.72 |
| Reserves | 6.56 | 19.77 | 21.38 | 22.39 |
| Total Assets | 27.59 | 54.59 | 59.33 | 68.46 |
| Total Liabilities | 27.59 | 54.59 | 59.33 | 68.46 |
Cash Flow
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| CFO/OP | — | 59 | -599 | -136 |
| Financing | — | 0.24 | 17.6 | 1.22 |
| Investing | — | 0.06 | 0 | -0.01 |
| Operating | — | -0.27 | -16.22 | -2.45 |
| Free Cash Flow | — | -0.27 | -16.24 | -2.51 |
| Net Cash Flow | — | 0.03 | 1.38 | -1.23 |
Ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Cash Conversion Cycle | — | 166 | 209 | 216 |
| Days Payable | — | 30.01 | 26.48 | 24.09 |
| Debtor Days | — | 113 | 151 | 144 |
| Inventory Days | — | 82.74 | 83.94 | 96.36 |
| ROCE % | — | — | 8.71% | 7.37% |
| Working Capital Days | — | 140 | 182 | 174 |
Documents
Financial Year 2025
from nse
from nse
Financial Year 2023
from nse
from nse
Financial Year 2024
from nse
from nse
Appointment
6 March 2026 - Appointed Bhaveshkumar Rajnikant Shah as Independent Director (6 Mar 2026–5 Mar 2031); committees reconstituted.
6 March 2026 - Appointed Bhaveshkumar Rajnikant Shah as Independent Director (6 Mar 2026–5 Mar 2031); committees reconstituted.
Outcome of Board Meeting
6 March 2026 - Appointed Bhaveshkumar R. Shah as Independent Director from 6 Mar 2026–5 Mar 2031; board committees reconstituted.
6 March 2026 - Appointed Bhaveshkumar R. Shah as Independent Director from 6 Mar 2026–5 Mar 2031; board committees reconstituted.
Trading Window
23 March 2026 - Trading window closed from 1 Apr 2026 until 48 hours after audited results for year ending 31 Mar 2026.
23 March 2026 - Trading window closed from 1 Apr 2026 until 48 hours after audited results for year ending 31 Mar 2026.
Reply to Clarification- Financial results
22 December 2025 - Approved unaudited standalone and consolidated results for H1 ended 30 Sep 2025; P&L page later filed.
22 December 2025 - Approved unaudited standalone and consolidated results for H1 ended 30 Sep 2025; P&L page later filed.
Updates
13 January 2026 - Yasons Chemex Care: corporate governance provisions not applicable for quarter ended 31-Dec-2025 due to SME listing.
13 January 2026 - Yasons Chemex Care: corporate governance provisions not applicable for quarter ended 31-Dec-2025 due to SME listing.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
13 January 2026 - Certificate under Reg 74(5) confirming dematerialisation details for quarter ended December 31, 2025.
13 January 2026 - Certificate under Reg 74(5) confirming dematerialisation details for quarter ended December 31, 2025.
Frequently Asked Questions about Yasons Chemex Care Ltd
What does Yasons Chemex Care Ltd do?
Incorporated in 2017, Yasons Chemex Care Ltd is in the business of Trading of chemicals and manufacturing of dyes and inter mediates and FMCG Products[1]
Where is Yasons Chemex Care Ltd (YCCL) listed?
Yasons Chemex Care Ltd is listed on the Indian stock exchanges. It is listed on NSE: YCCL. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Yasons Chemex Care Ltd belong to?
Yasons Chemex Care Ltd operates in the Commodities sector within the Dyes And Pigments industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Yasons Chemex Care Ltd?
Yasons Chemex Care Ltd has a market capitalisation of approximately ₹17.86 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Yasons Chemex Care Ltd?
The Price-to-Earnings (PE) ratio of Yasons Chemex Care Ltd is 11.00. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Yasons Chemex Care Ltd?
Over the past 52 weeks, Yasons Chemex Care Ltd has traded between a low of ₹9.15 and a high of ₹15.4. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Yasons Chemex Care Ltd?
Yasons Chemex Care Ltd has a Return on Equity (ROE) of 16.54%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Yasons Chemex Care Ltd on Tapetide?
On Tapetide, you can view Yasons Chemex Care Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 2017, Yasons Chemex Care Ltd is in the business of Trading of chemicals and manufacturing of dyes and inter mediates and FMCG Products[1]